pharmaceutical investing BioCryst Announces Publication of APeX-1 Clinical Trial Results for BCX7353 in The New England Journal of Medicine
pharmaceutical investing BioCryst Reports Agreement with PMDA on Phase 3 Clinical Trial and Regulatory Requirements for Marketing Authorization of BCX7353 in Japan
Skyharbour Partner Company Terra Clean Energy Announces Fraser Lakes B Deposit Recognized by Government of Canada as Active Rare Earth Deposit
Apple unveils new 14-inch MacBook Pro powered by the M5 chip, delivering the next big leap in AI for the Mac
